2005Zhongguo jiceng yiyaoRequires access

A controlled study of lithium carbonate with risperidone versus haloperidol in the treatment of mania

ZU Xian-yon

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of risperidone in the mania.Methods Seventy patients with mania were randomly assigned into the treatment groups of risperidone or haloperidol for 4 weeks,two groups were buspironed with lithium carbonate BRMS and scores were used to measure their efficacy,and investigate EPS.Results Took effects after the treatment of 2 weeks in both groups,there was no significant difference.But total BRMS scale decreased significantly more in risperdone group than that in haloperidol group after the treatment of 4 weeks,and the prevalence of EPS in risperidone group was lower than that in haloperidol group.Conclusion Risperidone is an effective and safe drug in the treatment of mania,and continuely effective.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of risperidone in the mania.Methods Seventy patients with mania were randomly assigned into the treatment groups of risperidone or haloperidol for 4 weeks,two groups were buspironed with lithium carbonate BRMS and scores were used to measure their efficacy,and investigate EPS.Results Took effects after the treatment of 2 weeks in both groups,there was no significant difference.But total BRMS scale decreased significantly more in risperdone group than that in haloperidol group after the treatment of 4 weeks,and the prevalence of EPS in risperidone group was lower than that in haloperidol group.Conclusion Risperidone is an effective and safe drug in the treatment of mania,and continuely effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of risperidone in the mania.Methods Seventy patients with mania were randomly assigned into the treatment groups of risperidone or haloperidol for 4 weeks,two groups were buspironed with lithium carbonate BRMS and scores were used to measure their efficacy,and investigate EPS.Results Took effects after the treatment of 2 weeks in both groups,there was no significant difference.But total BRMS scale decreased significantly more in risperdone group than that in haloperidol group after the treatment of 4 weeks,and the prevalence of EPS in risperidone group was lower than that in haloperidol group.Conclusion Risperidone is an effective and safe drug in the treatment of mania,and continuely effective.

Key concepts: Haloperidol, Risperidone, Mania, Lithium carbonate, Medicine, Lithium (medication), Internal medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
A controlled study of lithium carbonate with risperidone versus haloperidol in the treatment of mania — Research Paper | ScholarLens